Impact of Francisella tularensis pilin homologs on pilus formation and virulence

Microbial Pathogenesis

Volumn 51, Issue 3, 2011, Pages 110-120

  Ark, Nicole M ^a   Mann, Barbara J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Adherence; Francisella; J774A.1; Mice; Pili

Indexed keywords

PILIN; PILIN E4 PROTEIN; PILIN E5 PROTEIN; PILIN E6 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL SECRETION SYSTEM; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM PILUS; CELL FUNCTION; CELL INTERACTION; CELL STRUCTURE; CONTROLLED STUDY; FRANCISELLA TULARENSIS; GENE; GENE DELETION; GENE FUNCTION; GENETIC CODE; IN VITRO STUDY; IN VIVO STUDY; MICROBIAL MORPHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PILIN E4 GENE; PILIN E5 GENE; PILIN E6 GENE; PILIN GENE; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TULAREMIA; WILD TYPE;

ANIMALS; BACTERIAL ADHESION; CELL LINE; DISEASE MODELS, ANIMAL; FIMBRIAE PROTEINS; FIMBRIAE, BACTERIAL; FRANCISELLA TULARENSIS; GENE DELETION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; RODENT DISEASES; SURVIVAL ANALYSIS; TULAREMIA; VIRULENCE; VIRULENCE FACTORS;

BACTERIA (MICROORGANISMS); FRANCISELLA; FRANCISELLA TULARENSIS; MURINAE; MUS;

EID: 79959364227     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.05.001     Document Type: Article

References (41)

1. Sjostedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci 2007, 1105:1-29.
2. Tarnvik A., Berglund L. Tularaemia Eur Respir J 2003, 21:361-373.
3. Saslaw S., Eigelsbach H.T., Prior J.A., Wilson H.E., Carhart S. Tularemia vaccine study. II. Respiratory challenge. Arch Intern Med 1961, 107:702-714.
4. Dennis D.T., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001, 285:2763-2773.
5. Khan A.S., Morse S., Lillibridge S. Public-health preparedness for biological terrorism in the USA. Lancet 2000, 356:1179-1182.
6. Champion M.D., Zeng Q., Nix E.B., Nano F.E., Keim P., Kodira C.D., et al. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog 2009, 5:e1000459.
7. Griffin K.F., Oyston P.C., Titball R.W. Francisella tularensis vaccines. FEMS Immunol Med Microbiol 2007, 49:315-323.
8. Rohmer L., Brittnacher M., Svensson K., Buckley D., Haugen E., Zhou Y., et al. Potential source of Francisella tularensis live vaccine strain attenuation determined by genome comparison. Infect Immun 2006, 74:6895-6906.
9. Salomonsson E., Kuoppa K., Forslund A.L., Zingmark C., Golovliov I., Sjostedt A., et al. Reintroduction of two deleted virulence loci restores full virulence to the live vaccine strain of Francisella tularensis. Infect Immun 2009, 77:3424-3431.
10. Larsson P., Oyston P.C., Chain P., Chu M.C., Duffield M., Fuxelius H.H., et al. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet 2005, 37:153-159.
11. Gil H., Benach J.L., Thanassi D.G. Presence of pili on the surface of Francisella tularensis. Infect Immun 2004, 72:3042-3047.
12. Mattick J.S., Whitchurch C.B., Alm R.A. The molecular genetics of type-4 fimbriae in Pseudomonas aeruginosa-a review. Gene 1996, 179:147-155.
13. Craig L., Pique M.E., Tainer J.A. Type IV pilus structure and bacterial pathogenicity. Nat Rev Microbiol 2004, 2:363-378.
14. Petrosino J.F., Xiang Q., Karpathy S.E., Jiang H., Yerrapragada S., Liu Y., et al. Chromosome rearrangement and diversification of Francisella tularensis revealed by the type B (OSU18) genome sequence. J Bacteriol 2006, 188:6977-6985.
15. Chain P., Larimer F., Land M., Stilwagen S., Larsson P., Bearden S., et al. Complete genome sequence of Francisella tularensis LVS (Live vaccine strain) 2006.
16. Rohmer L., Fong C., Abmayr S., Wasnick M., Larson Freeman T.J., Radey M., et al. Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains. Genome Biol 2007, 8:R102.
17. Hager A.J., Bolton D.L., Pelletier M.R., Brittnacher M.J., Gallagher L.A., Kaul R., et al. Type IV pili-mediated secretion modulates Francisella virulence. Mol Microbiol 2006, 62:227-237.
18. Vignon G., Kohler R., Larquet E., Giroux S., Prevost M.C., Roux P., et al. Type IV-like pili formed by the type II secreton: specificity, composition, bundling, polar localization, and surface presentation of peptides. J Bacteriol 2003, 185:3416-3428.
19. Durand E., Bernadac A., Ball G., Lazdunski A., Sturgis J.N., Filloux A. Type II protein secretion in Pseudomonas aeruginosa: the pseudopilus is a multifibrillar and adhesive structure. J Bacteriol 2003, 185:2749-2758.
20. Kirn T.J., Bose N., Taylor R.K. Secretion of a soluble colonization factor by the TCP type 4 pilus biogenesis pathway in Vibrio cholerae. Mol Microbiol 2003, 49:81-92.
21. Zogaj X., Chakraborty S., Liu J., Thanassi D.G., Klose K.E. Characterization of the Francisella tularensis subsp. novicida type IV pilus. Microbiology 2008, 154:2139-2150.
22. Chakraborty S., Monfett M., Maier T.M., Benach J.L., Frank D.W., Thanassi D.G. Type IV pili in Francisella tularensis: roles of pilF and pilT in fiber assembly, host cell adherence, and virulence. Infect Immun 2008, 76:2852-2861.
23. Forsberg A., Guina T. Type II secretion and type IV pili of Francisella. Ann N Y Acad Sci 2007, 1105:187-201.
24. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-4680.
25. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
26. Sheffield P., Garrard S., Derewenda Z. Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. Protein Expr Purif 1999, 15:34-39.
27. Qin A., Mann B.J. Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2. BMC Microbiol 2006, 6:69.
28. Maier T.M., Havig A., Casey M., Nano F.E., Frank D.W., Zahrt T.C. Construction and characterization of a highly efficient Francisella shuttle plasmid. Appl Environ Microbiol 2004, 70:7511-7519.
29. Maier T.M., Pechous R., Casey M., Zahrt T.C., Frank D.W. In vivo Himar1-based transposon mutagenesis of Francisella tularensis. Appl Environ Microbiol 2006, 72:1878-1885.
30. Strom M.S., Lory S. Structure-function and biogenesis of the type IV pili. Annu Rev Microbiol 1993, 47:565-596.
31. Pelicic V. Type IV pili: e pluribus unum?. Mol Microbiol 2008, 68:827-837.
32. Sohel I., Puente J.L., Ramer S.W., Bieber D., Wu C.Y., Schoolnik G.K. Enteropathogenic Escherichia coli: identification of a gene cluster coding for bundle-forming pilus morphogenesis. J Bacteriol 1996, 178:2613-2628.
33. Salomonsson E.M., Forsberg A., Roos N., Holz C., Maier B., Koomey M., et al. Functional analyses of pilin-like proteins from Francisella species: complementation of type IV pilus phenotypes in. Neisseria gonorrhoeae Microbiol 2009.
34. Lai X.H., Shirley R.L., Crosa L., Kanistanon D., Tempel R., Ernst R.K., et al. Mutations of Francisella novicida that alter the mechanism of its phagocytosis by murine macrophages. PLoS One 2010, 5:e11857.
35. Forslund A.L., Naslund Salomonsson E., Golovliov I., Kuoppa K., Michell S., Titball R., et al. The type IV pilin, PilA, is required for full virulence of Francisella tularensis subspecies tularensis. BMC Microbiol 2010, 10:227.
36. Qin A., Scott D.W., Mann B.J. Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence. Infect Immun 2008, 76:3086-3092.
37. Bina X.R., Lavine C.L., Miller M.A., Bina J.E. The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice. FEMS Microbiol Lett 2008, 279:226-233.
38. Lindgren H., Shen H., Zingmark C., Golovliov I., Conlan W., Sjostedt A. Resistance of Francisella tularensis strains against reactive nitrogen and oxygen species with special reference to the role of KatG. Infect Immun 2007, 75:1303-1309.
39. Forslund A.L., Kuoppa K., Svensson K., Salomonsson E., Johansson A., Bystrom M., et al. Direct repeat-mediated deletion of a type IV pilin gene results in major virulence attenuation of Francisella tularensis. Mol Microbiol 2006, 59:1818-1830.
40. Durham-Colleran M.W., Verhoeven A.B., van Hoek M.L. Francisella novicida forms in vitro biofilms mediated by an orphan response regulator. Microb Ecol 2009.
41. Ramakrishnan G., Meeker A., Dragulev B. fslE is necessary for siderophore-mediated iron acquisition in Francisella tularensis Schu S4. J Bacteriol 2008, 190:5353-5361.